HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

Market Cap	140.55B
Revenue (ttm)	126.18B
Net Income (ttm)	-4.03B
Shares Out	30.00M
EPS (ttm)	-134.25
PE Ratio	11.24
Forward PE	7.68
Dividend	35.00 (0.73%)
Ex-Dividend Date	Dec 27, 2024

Volume	121,643
Average Volume	187,294
Open	4,790.00
Previous Close	4,790.00
Day's Range	4,725.00 - 4,915.00
52-Week Range	3,825.00 - 5,970.00
Beta	0.88
RSI	45.90
Earnings Date	Aug 4, 2025

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pha...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 341
• Stock Exchange: KOSDAQ
• Ticker Symbol: 052260

Financial Performance

In 2024, HYUNDAI BIOLAND's revenue was 119.52 billion, an increase of 23.57% compared to the previous year's 96.72 billion. Earnings were 5.70 billion, a decrease of -29.21%.